Topic: Rubella

A Mayo Clinic study found that African Americans, specifically Somali Americans, exhibit significantly higher antibody responses to the rubella vaccine compared to Caucasians. This finding supports the concept of personalized medicine, suggesting that standard vaccine dosages may not be appropriate for all ethnic groups. The lack of peer-reviewed media coverage on these biological differences is criticized as a form of systemic oversight.

Future medical practices may involve adjusting vaccine dosages based on a person's genetic profile rather than race. Suggestions include giving African Americans half-doses of certain vaccines if their immune response is naturally stronger. Critics argue that using Black populations to establish baselines for "personalized" medicine before rolling it out to wealthier demographics is ethically problematic.